Mordor Intelligence has published a new report on hematology diagnostics market, offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
The hematology diagnostics market stands at USD 4.22 billion in 2025 and is forecast to reach USD 5.84 billion by 2030, expanding at a 6.69% CAGR over the period. This growth reflects a compound annual growth rate (CAGR) of about 6.69% during the forecast period. Increasing demand for faster, more reliable blood-analysis tools, rising burdens of blood-related diseases, and growing adoption of modern diagnostic technologies are reshaping how hematology testing is delivered worldwide. As healthcare providers prioritize timely diagnosis and treatment, the hematology diagnostics market is becoming ever more central to effective medical care.
Key Trends
Several important trends are shaping the future of the hematology diagnostics market, reflecting shifts in technology, clinical needs, and market demand.
Automation and Lab Efficiency
Laboratories across the globe are increasingly adopting fully automated analyzers that streamline routine blood tests. These systems reduce manual steps significantly and lower error rates in sample processing. Such automation helps labs manage higher throughput while dealing with workforce shortages, improving both speed and reliability of testing.
Shift Toward Point-of-Care and Distributed Testing
The increasing availability of compact, easy-to-use analyzers enables hematology testing beyond traditional hospital laboratories. Point-of-care (POC) and even home-care settings are becoming realistic venues for tests like complete blood counts (CBC) and HbA1c. This shift broadens access to diagnostics, particularly in outpatient settings or regions where conventional labs may be scarce.
Rise of Digital Hematology and Advanced Technologies
Another significant trend is growing use of molecular and digital hematology technologies including digital morphology, automated flow cytometry, and AI-assisted cell analysis. These advanced platforms deliver deeper insights, such as better detection of abnormal cells, genetic markers, and detailed blood-disorder diagnostics.
Market Segmentation
A look at how the hematology diagnostics market is segmented helps illustrate where demand is coming from and which areas are growing fastest.
By Product & Service
By Test Type
- Complete Blood Count (CBC)
- Coagulation & Hemostasis
- HbA1c & Specialized Tests
By End User
- Independent/Reference Labs
- Academic & Research Institutes
By Technology
- 3-part Differential Analyzers
- 5/6-part Differential Analyzers
- Automated Flow Cytometry
- Molecular & Digital Hematology
By Geography
Key Players
The hematology diagnostics market combines a mix of well-established multinational firms and more recent entrants focusing on digital or decentralized solutions. Among the leading players:
- F. Hoffmann-La Roche Ltd
Beyond these incumbents, newer players and startups are challenging the status quo by introducing AI-enabled, miniaturized hematology devices, and software-driven models (such as cloud-based morphology review and reagent-restocking service contracts) that appeal to smaller clinics and decentralized care centers.
Conclusion
The hematology diagnostics market is on a steady upward trajectory, with clear signals that laboratories and healthcare providers are growing increasingly focused on speed, accuracy, and broader access to blood diagnostics. Rising demand for routine CBCs, increasing burden of chronic diseases and blood disorders, and a shift toward decentralized and point-of-care testing are major factors fueling market growth.
Simultaneously, adoption of digital hematology, molecular testing, and software-enabled lab workflows is reshaping how diagnostics are delivered, enabling labs to handle complex workloads with fewer manual interventions. As instruments, consumables, and software evolve in tandem, the hematology diagnostics market is set to expand both in scale (market size) and scope (application areas).
Industry related Reports:
Point-of-Care Hematology Diagnostics Market: The Point-Of-Care (POC) Hematology Diagnostics Market is Segmented by Product (Systems and Consumables) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Clinical Laboratory Services Market: The Clinical Laboratory Services Market Report is Segmented by Test Type (Clinical Chemistry, Immunology/Serology, and More), Service Provider (Hospital-Based Laboratories, Stand-Alone/Independent Laboratories, and More), Application (Infectious Disease Testing, Oncology & Tumor Marker Testing, and More), and Geography (North America, Europe, Asia-Pacific, and More).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
